Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & GamblefiledCriticalProcter & Gamble
Priority to CO94047643ApriorityCriticalpatent/CO4180553A1/en
Publication of CO4180553A1publicationCriticalpatent/CO4180553A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
PROVEER UNA COMPOSICION DE ADMINISTRACION ORAL PA- RA EL TRATAMIENTO DE LA PERIDONTITIS ADULTA, COM- POSICION QUE COMPRENDE UNA CANTIDAD DE AZITROMICI- NA, UN SISTEMA DE DISPENSACION PAULATINA Y SOSTE- NIDA Y UN SUSPENSOR ORAL TOPICO FARMACEUTICAMENTE ACEPTABLE.PROVIDING AN ORAL ADMINISTRATION COMPOSITION FOR THE TREATMENT OF ADULT PERIDONTITIS, A COMPOSITION THAT INCLUDES A QUANTITY OF AZITROMIZINE, A SUSTAINABLE, DELIVERY SYSTEM AND A TOPIC PHARMACEUTICALLY ACCEPTABLE SUSPENSOR.
CO94047643A1994-10-191994-10-19
COMPOSITIONS FOR THE TREATMENT OF ADULT PERIDONTITIS
CO4180553A1
(en)
USE OF CLORPROMAZINE AND PENTAMIDINE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL PACKAGE THAT INCLUDE CHLORPROMAZINE AND PENTAMIDINE.